Holen Sie sich die Stockscreener-App
0.974
3.03%
-0.016
Schlusskurs vom Vortag:
$0.99
Offen:
$0.98
24-Stunden-Volumen:
23,251
Relative Volume:
0.10
Marktkapitalisierung:
$37.58M
Einnahmen:
$63.15M
Nettoeinkommen (Verlust:
$-40.30M
KGV:
-0.5832
EPS:
-1.67
Netto-Cashflow:
$-44.47M
1W Leistung:
-3.08%
1M Leistung:
-4.00%
6M Leistung:
-67.12%
1J Leistung:
-83.95%
1-Tages-Spanne:
$0.96
$1.03
1-Wochen-Bereich:
$0.9501
$1.14
52-Wochen-Spanne:
$0.8645
$6.50
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Vergleichen Sie TELA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.974 | 37.58M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
132.10 | 233.05B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.27 | 155.05B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
390.89 | 146.77B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
85.48 | 106.66B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
76.59 | 44.02B | 5.54B | 4.18B | 623.10M | 7.00 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio Reports Q1 2025 Growth and Product Expansion - MSN
TELA Bio Announces Inducement Grants to New Hires with 4-Year Vesting Plan - MSN
TELA Bio announces inducement grants - Medical Buyer
TELA Bio, Inc. (NASDAQ:TELA) Q1 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5 - GuruFocus
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TELA Stock News - GuruFocus
TELA Bio revenue up 12% to USD 18.5 million in Q1 2025 - Medical Buyer
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Challenges - Yahoo Finance
TELA Bio Inc (TELA) Q1 2025 Earnings Call Highlights: Strong Rev - GuruFocus
TELA Bio (NASDAQ:TELA) vs. Inspire Medical Systems (NYSE:INSP) Critical Contrast - The AM Reporter
TELA Bio Reports Strong Q1 2025 Revenue Growth - TipRanks
TELA Bio Reports First Quarter 2025 Financial Results - GlobeNewswire
Earnings call transcript: Tela Bio Q1 2025 revenue miss, stock rises 9% - Investing.com India
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
TELA Bio Reports Q1 2025 Revenue Growth Amid Losses - TipRanks
TELA Bio Inc (TELA) Q1 2025 Earnings Report Preview: What to Expect - Yahoo Finance
Inspire Medical Systems (NYSE:INSP) & TELA Bio (NASDAQ:TELA) Critical Analysis - Defense World
TELA Bio Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Short Interest in TELA Bio, Inc. (NASDAQ:TELA) Drops By 14.6% - Defense World
Short Interest in TELA Bio, Inc. (NASDAQ:TELA) Declines By 14.6% - The AM Reporter
Favourable Signals For TELA Bio: Numerous Insiders Acquired Stock - Yahoo Finance
JPMorgan Chase & Co. Increases Stock Holdings in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Geode Capital Management LLC Buys 136,890 Shares of TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Renaissance Technologies LLC Has $1.28 Million Stake in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Critical Analysis: TELA Bio (NASDAQ:TELA) & Retractable Technologies (NYSE:RVP) - Defense World
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with ... - Yahoo
TELA Bio Inc (TELA) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges with Strategic Initiatives - GuruFocus
TELA Bio to Announce Q1 2025 Earnings on May 8 - MSN
TELA Bio to Announce First Quarter 2025 Financial Results | TELA Stock News - GuruFocus
TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewswire
TELA Bio, Inc. (NASDAQ:TELA) Stock Position Boosted by Commonwealth Equity Services LLC - Defense World
Prudential Financial Inc. Takes $57,000 Position in TELA Bio, Inc. (NASDAQ:TELA) - Defense World
Tela Bio slumps after Q4 miss as Piper Sandler downgrades - MSN
TELA Bio Expands OviTex PRS Line with Larger Surgical Sizes - MSN
Canaccord maintains TELA Bio stock with $7 target post-challenges By Investing.com - Investing.com Canada
Canaccord maintains TELA Bio stock with $7 target post-challenges - Investing.com
Tela Bio stock plunges to 52-week low of $1.13 amid market challenges - Investing.com Canada
Not Many Are Piling Into TELA Bio, Inc. (NASDAQ:TELA) Stock Yet As It Plummets 50% - simplywall.st
TELA Bio introduces larger sizes for soft tissue reconstruction - Investing.com India
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery - GlobeNewswire
Revolutionary Expansion: TELA Bio's New OviTex PRS Sizes Set Industry Record as Sales Surge 31% - Stock Titan
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tela Bio Inc-Aktie (TELA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Talmo Paul | Chief Technology Officer |
Oct 24 '24 |
Buy |
2.25 |
22,222 |
50,000 |
91,082 |
| KOBLISH ANTONY | Chief Executive Officer |
Oct 24 '24 |
Buy |
2.25 |
88,888 |
199,998 |
458,897 |
| Firestone Gregory A. | Chief Commercial Officer |
Oct 24 '24 |
Buy |
2.25 |
6,666 |
14,998 |
57,279 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jun 28 '24 |
Sale |
4.74 |
378,000 |
1,791,720 |
2,457,542 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 02 '24 |
Sale |
4.54 |
36,600 |
166,164 |
2,407,242 |
| ORBIMED ADVISORS LLC | 10% Owner |
Jul 01 '24 |
Sale |
4.68 |
13,700 |
64,116 |
2,443,842 |
0.73%
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):